Science Scientific Biology Biotechnology DNAVEC CORPORATION
DNAVEC CORPORATION
Production and the like of the development of the gene remedy formulation which is based on vector technology, development of the gene vaccine and rearrangement protein.
Types Ecommerce
-B2B (Business-to-Business)
Staff
Mamoru Hasegawa, Ph D.
Position
Representative
Employment
35
Set up: 2003
Capital: 1,079,150,000
Map
Reviews (0)
Be the first to review this listing!
Google Advertise
Who's Online
We have 913 guests online